vs
Axos Financial, Inc.（AX）与Sotera Health Co（SHC）财务数据对比。点击上方公司名可切换其他公司
Axos Financial, Inc.的季度营收约是Sotera Health Co的1.3倍（$392.2M vs $303.4M），Axos Financial, Inc.净利率更高（31.8% vs 11.5%，领先20.3%），过去两年Axos Financial, Inc.的营收复合增速更高（16.1% vs 10.6%）
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司，旗下拥有直销银行Axos Bank，同时提供注册投资顾问服务及电子交易平台，深耕数字化金融赛道，可为用户提供多元便捷的金融服务解决方案。
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
AX vs SHC — 直观对比
营收规模更大
AX
是对方的1.3倍
$303.4M
净利率更高
AX
高出20.3%
11.5%
两年增速更快
AX
近两年复合增速
10.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $392.2M | $303.4M |
| 净利润 | $124.7M | $34.8M |
| 毛利率 | — | 54.7% |
| 营业利润率 | — | 23.2% |
| 净利率 | 31.8% | 11.5% |
| 营收同比 | — | 4.6% |
| 净利润同比 | 18.5% | 182.8% |
| 每股收益（稀释后） | $2.15 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSHC
| Q1 26 | $392.2M | — | ||
| Q4 25 | $385.1M | $303.4M | ||
| Q3 25 | $323.4M | $311.3M | ||
| Q2 25 | $321.4M | $294.3M | ||
| Q1 25 | $308.8M | $254.5M | ||
| Q4 24 | $307.9M | $290.2M | ||
| Q3 24 | $320.7M | $285.5M | ||
| Q2 24 | $290.9M | $276.6M |
净利润AXSHC
| Q1 26 | $124.7M | — | ||
| Q4 25 | $128.4M | $34.8M | ||
| Q3 25 | $112.4M | $48.4M | ||
| Q2 25 | $110.7M | $8.0M | ||
| Q1 25 | $105.2M | $-13.3M | ||
| Q4 24 | $104.7M | $12.3M | ||
| Q3 24 | $112.3M | $17.0M | ||
| Q2 24 | $104.9M | $8.8M |
毛利率AXSHC
| Q1 26 | — | — | ||
| Q4 25 | — | 54.7% | ||
| Q3 25 | — | 57.0% | ||
| Q2 25 | — | 56.6% | ||
| Q1 25 | — | 53.2% | ||
| Q4 24 | — | 56.6% | ||
| Q3 24 | — | 55.4% | ||
| Q2 24 | — | 55.2% |
营业利润率AXSHC
| Q1 26 | — | — | ||
| Q4 25 | 45.6% | 23.2% | ||
| Q3 25 | 46.3% | 23.4% | ||
| Q2 25 | 48.5% | 6.4% | ||
| Q1 25 | 47.9% | -5.8% | ||
| Q4 24 | 48.8% | 30.0% | ||
| Q3 24 | 49.6% | 28.2% | ||
| Q2 24 | 49.6% | 27.8% |
净利率AXSHC
| Q1 26 | 31.8% | — | ||
| Q4 25 | 33.3% | 11.5% | ||
| Q3 25 | 34.7% | 15.5% | ||
| Q2 25 | 34.4% | 2.7% | ||
| Q1 25 | 34.1% | -5.2% | ||
| Q4 24 | 34.0% | 4.2% | ||
| Q3 24 | 35.0% | 6.0% | ||
| Q2 24 | 36.0% | 3.2% |
每股收益（稀释后）AXSHC
| Q1 26 | $2.15 | — | ||
| Q4 25 | $2.22 | $0.12 | ||
| Q3 25 | $1.94 | $0.17 | ||
| Q2 25 | $1.89 | $0.03 | ||
| Q1 25 | $1.81 | $-0.05 | ||
| Q4 24 | $1.80 | $0.05 | ||
| Q3 24 | $1.93 | $0.06 | ||
| Q2 24 | $1.75 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $344.6M |
| 总债务越低越好 | — | $2.1B |
| 股东权益账面价值 | $3.1B | $606.0M |
| 总资产 | $29.2B | $3.3B |
| 负债/权益比越低杠杆越低 | — | 3.53× |
8季度趋势，按日历期对齐
现金及短期投资AXSHC
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $344.6M | ||
| Q3 25 | $2.6B | $299.2M | ||
| Q2 25 | $1.9B | $332.4M | ||
| Q1 25 | $2.0B | $304.4M | ||
| Q4 24 | $2.4B | $277.2M | ||
| Q3 24 | $2.6B | $306.7M | ||
| Q2 24 | $2.0B | $246.1M |
总债务AXSHC
| Q1 26 | — | — | ||
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | $312.7M | $2.2B | ||
| Q1 25 | $377.4M | $2.2B | ||
| Q4 24 | $358.7M | $2.2B | ||
| Q3 24 | $313.5M | $2.2B | ||
| Q2 24 | $325.7M | $2.2B |
股东权益AXSHC
| Q1 26 | $3.1B | — | ||
| Q4 25 | $2.9B | $606.0M | ||
| Q3 25 | $2.8B | $550.5M | ||
| Q2 25 | $2.7B | $511.3M | ||
| Q1 25 | $2.6B | $414.1M | ||
| Q4 24 | $2.5B | $404.9M | ||
| Q3 24 | $2.4B | $470.2M | ||
| Q2 24 | $2.3B | $422.8M |
总资产AXSHC
| Q1 26 | $29.2B | — | ||
| Q4 25 | $28.2B | $3.3B | ||
| Q3 25 | $27.4B | $3.2B | ||
| Q2 25 | $24.8B | $3.2B | ||
| Q1 25 | $24.0B | $3.1B | ||
| Q4 24 | $23.7B | $3.1B | ||
| Q3 24 | $23.6B | $3.1B | ||
| Q2 24 | $22.9B | $3.1B |
负债/权益比AXSHC
| Q1 26 | — | — | ||
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.89× | ||
| Q2 25 | 0.12× | 4.34× | ||
| Q1 25 | 0.14× | 5.36× | ||
| Q4 24 | 0.14× | 5.49× | ||
| Q3 24 | 0.13× | 4.73× | ||
| Q2 24 | 0.14× | 5.26× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $103.1M |
| 自由现金流经营现金流 - 资本支出 | — | $52.4M |
| 自由现金流率自由现金流/营收 | — | 17.3% |
| 资本支出强度资本支出/营收 | — | 16.7% |
| 现金转化率经营现金流/净利润 | — | 2.96× |
| 过去12个月自由现金流最近4个季度 | — | $149.2M |
8季度趋势，按日历期对齐
经营现金流AXSHC
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $103.1M | ||
| Q3 25 | $118.4M | $71.2M | ||
| Q2 25 | $490.3M | $57.4M | ||
| Q1 25 | $73.7M | $55.5M | ||
| Q4 24 | $162.5M | $55.7M | ||
| Q3 24 | $70.8M | $97.5M | ||
| Q2 24 | $305.5M | $61.3M |
自由现金流AXSHC
| Q1 26 | — | — | ||
| Q4 25 | $85.4M | $52.4M | ||
| Q3 25 | $109.3M | $35.0M | ||
| Q2 25 | $436.1M | $26.2M | ||
| Q1 25 | $65.1M | $35.6M | ||
| Q4 24 | $156.4M | $-10.2M | ||
| Q3 24 | $53.0M | $61.1M | ||
| Q2 24 | $269.5M | $19.4M |
自由现金流率AXSHC
| Q1 26 | — | — | ||
| Q4 25 | 22.2% | 17.3% | ||
| Q3 25 | 33.8% | 11.2% | ||
| Q2 25 | 135.7% | 8.9% | ||
| Q1 25 | 21.1% | 14.0% | ||
| Q4 24 | 50.8% | -3.5% | ||
| Q3 24 | 16.5% | 21.4% | ||
| Q2 24 | 92.6% | 7.0% |
资本支出强度AXSHC
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 16.7% | ||
| Q3 25 | 2.8% | 11.6% | ||
| Q2 25 | 16.9% | 10.6% | ||
| Q1 25 | 2.8% | 7.8% | ||
| Q4 24 | 2.0% | 22.7% | ||
| Q3 24 | 5.5% | 12.7% | ||
| Q2 24 | 12.4% | 15.2% |
现金转化率AXSHC
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | 2.96× | ||
| Q3 25 | 1.05× | 1.47× | ||
| Q2 25 | 4.43× | 7.21× | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 1.55× | 4.52× | ||
| Q3 24 | 0.63× | 5.73× | ||
| Q2 24 | 2.91× | 7.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
